Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationStability of thromboxane in blood samples. 2019, 15: 143-147 Vasc Health Risk Manag
AbstractIntroduction: Conventional venous blood collection requires a puncture with a needle through the endothelium of a vessel. The endothelial injury causes activation of circulating platelets and the release of thromboxane A2. The aim of the study was to investigate if platelets continue to form thromboxane A2 in the blood tube after sample collection, but such synthesis would give false information about the actual circulating thromboxane A2 value. Methods: Thromboxane B2 is a biologically inactive but stable metabolite of thromboxane A2 and can be measured in blood samples by a standard enzyme immunoassay. Thromboxane B2 measurements reflect thromboxane A2 concentration. Blood samples were collected in 3.2% sodium citrate vials and EDTA vials from ten individuals and centrifuged and frozen at different time points (0, 30, and 120 minutes). Plasma aliquots were transferred to and frozen in 1.8 mL polypropylene tubes and the citrate samples were also transferred to and frozen in propylene tubes containing indomethacin. Results: Concentrations of thromboxane B2 in plasma samples collected in citrate vials and stored in propylene tubes increased very rapidly as the samples were left for longer after sampling and allowed to stand at room temperature. After 120 minutes, the amount of thromboxane B2 was 400% higher than in the reference sample at time zero. In comparison, thromboxane B2 concentration was about 200% higher in the 120-minute samples compared to the reference in samples collected in citrate vials but stored in indomethacin tubes. In samples collected in EDTA vials, a 10% reduction in thromboxane B2 concentration in the 120-minute samples was observed. Conclusion: Storage conditions, type of sampling vial and time from sampling until sample processing (centrifuging) has a major impact on thromboxane B2 stability.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download
- Passive smoking and platelet thromboxane.
- Authors: Schmid P, Karanikas G, Kritz H, Pirich C, Stamatopoulos Y, Peskar BA, Sinzinger H
- Issue date: 1996 Feb 15
- [Collection, preparation and storage of human plasma for radioimmunologic determination of thromboxane B2].
- Authors: Nell A, Kment G, Matejka M, Porteder H, Peskar BA, Sinzinger H
- Issue date: 1988 Nov 4
- The effect of selected pre-analytical phase variables on plasma thromboxane A₂ measurements in humans.
- Authors: Sadilkova L, Paluch Z, Mottlova J, Bednar F, Alusik S
- Issue date: 2013 Feb
- Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS.
- Authors: Perneby C, Granström E, Beck O, Fitzgerald D, Harhen B, Hjemdahl P
- Issue date: 1999 Dec 15
- Temperature and time-dependent effects of delayed blood processing on oxylipin concentrations in human plasma.
- Authors: Ramsden CE, Yuan ZX, Horowitz MS, Zamora D, Majchrzak-Hong SF, Muhlhausler BS, Taha AY, Makrides M, Gibson RA
- Issue date: 2019 Nov